NLRP3 and brain infarction: Finally, NLRP3 inhibitors, such as MCC950, have been reported to successfully inhibit the activation of NLRP3 after ischemic stroke and alleviate cerebral infarct size, pyroptosis and neuronal apoptosis, and neurological dysfunction [93].